Changes in MD and oard positions impress me. Focus is now heavily on medical products using the retractale syringe as a asis for further products. My feeling is that the syringe will be a goer, and soon, as they are already talking about using the technology for a retractable catheta.
Good times ahead.
J.
- Forums
- ASX - By Stock
- ALT
- structural changes
structural changes
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online